SEC Form 4 · accession 0001396677-15-000039

NUTRACEUTICAL INTERNATIONAL CORP · NUTR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Vice President and CFO

Period of report

Aug 10, 2015

Accepted (ET)

Aug 12, 2015 · 12:26 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001050007

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 10, 2015	M	2,500	$14.22	A	25,274	D
Common Stock^F2	Aug 10, 2015	S	2,500	$24.8512	D	22,774	D
Common Stock	Aug 11, 2015	M	5,000	$14.22	A	27,774	D
Common Stock^F3	Aug 11, 2015	S	2,900	$24.4959	D	24,874	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$14.22	Aug 10, 2015	M	2,500	D	Sep 30, 2005	Sep 30, 2015	Common Stock	2,500	5,000	D
Employee Stock Option (right to buy)^F4	$14.22	Aug 11, 2015	M	5,000	D	Sep 30, 2005	Sep 30, 2015	Common Stock	5,000	0	D

F1Exercise of options expiring on September 30, 2015.
F2The price shown in Column 4 is a weighted average sale price. The price range for the sales is $24.74 to $24.97. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3The price shown in Column 4 is a weighted average sale price. The price range for the sales is $24.40 to $24.54. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4The options immediately vested at the time of grant.